SAB Biotherapeutics (NasdaqCM:SABS) FY Conference Transcript

SAB Biotherapeutics (NasdaqCM:SABS) FY Conference February 25, 2026 08:40 AM ET Company ParticipantsSam J. Reich - CEOConference Call ParticipantsLeland Gershell - Biotechnology AnalystLeland GershellGreat. Thank you, and welcome everyone to our next presenting company here at Oppenheimer's 36th Annual Healthcare Life Sciences Conference. I'm Leland Gershell, one of the Biotech Analysts with the firm. We are gratified and delighted to have with us SAB Biotherapeutics. The ticker is SABS, which we cover with ...